National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 54605-54606 [2018-23613]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices
development and evaluation under a
research collaboration.
Potential Commercial Applications
• Novel therapeutics for
neurodegenerative diseases AND other
indications which involve c-Abl kinase
(e.g., lysosomal storage disorders,
cancers, etc.).
Competitive Advantages
• Novel compounds that have a
commercial advantage over those
currently known because they are able
to selectively bind to c-Abl at an
allosteric site, can cross the blood-brain
barrier, and show robust efficacy in
several neurodegenerative models. All
of this allows them to potentially treat
neurodegenerative diseases, cancer etc.
Development Stage
• Pre-Clinical (in vivo validation).
Inventors
• Juan Marugan, Marc Ferrer, Noel
Southall, Andres Dulcey, Xin Hu,
Christopher Dextras, Daniel Talley,
Alejandra Alvarez, Silvana Zanlungo.
Intellectual Property: 1. C-ABL
TYROSINE KINASE INHIBITORY
COMPOUND EMBODIMENTS AND
METHODS OF MAKING AND USING
THE SAME’’ U.S. Provisional Patent
Application NO. 62/641,126 filed on
March 9, 2018 (HHS Ref. No. E–252–
2017).
Licensing Contact: Ami Gadhia, JD,
LL.M., CLP, 301–217–6098;
ami.gadhia@nih.gov.
Dated: September 25, 2018.
Lillianne M. Portilla Weingarten,
Technology Development Coordinator,
National Center for Advancing Translational
Sciences.
[FR Doc. 2018–23616 Filed 10–29–18; 8:45 am]
BILLING CODE 4140–01–P
khammond on DSK30JT082PROD with NOTICES
Jkt 247001
Dated: October 24, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–23614 Filed 10–29–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Ancillary
Studies Application Review.
Date: November 2, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
Name of Committee: National Institute on
Aging Special Emphasis Panel; Second Stage
Review.
Date: November 19, 2018.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892.
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
National Institute on Aging; Notice of
Closed Meeting
BILLING CODE 4140–01–P
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2018–23615 Filed 10–29–18; 8:45 am]
National Institutes of Health
21:27 Oct 29, 2018
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD K99
Teleconference Review.
Date: November 29, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20894
(Telephone Conference Call).
Contact Person: Helen Huang, Scientific
Review Branch (SRB), DER, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS,
6710B Rockledge Drive, Rm. 2125B,
Bethesda, MD 20817, 301–435–8380,
helen.huang@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Pediatric Critical
Care and Trauma Scientist Development
Program (K12) Teleconference Review.
Date: December 3, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Helen Huang, Scientific
Review Branch (SRB), DER, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, NIH, DHHS,
6710B Rockledge Drive, Rm. 2125B,
Bethesda, MD 20817, 301–435–8380,
helen.huang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 24, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
54605
National Institutes of Health
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\30OCN1.SGM
30OCN1
khammond on DSK30JT082PROD with NOTICES
54606
Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices
Place: National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 814, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 800, Bethesda,
MD 20892, 301–594–4952, linh1@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; NIAMS
Skin P30 Review Meeting.
Date: November 5–6, 2018.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 814, Bethesda,
MD 20892, 301–451–4838, mak2@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Training
Grants Review.
Date: November 14, 2018.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: 6701 Democracy Boulevard, Suite
820, Scientific Review Branch, National
Institute of Arthritis, Musculoskeletal and
Skin Diseases, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases 6701
Democracy Boulevard, Suite 820, Bethesda,
MD 20892, 301–827–7835,
yasuko.furumoto@nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; MSK P30
Review Meeting.
Date: November 15–16, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, Bethesda, MD 20852.
Contact Person: Yin Liu, MD, Ph.D.,
Scientific Review Branch, National Institute
of Health, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Suite 824, Bethesda,
MD 20892, 301–594–8919, liuy@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
VerDate Sep<11>2014
17:34 Oct 29, 2018
Jkt 247001
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Public Participation and Request for
Comments
Dated: October 24, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
This Notice relies on the authority of
the Paperwork Reduction Act of 1995;
44 U.S.C. chapter 35, as amended. An
ICR is an application to OIRA seeking
the approval, extension, or renewal of a
Coast Guard collection of information
(Collection). The ICR contains
information describing the Collection’s
purpose, the Collection’s likely burden
on the affected public, an explanation of
the necessity of the Collection, and
other important information describing
the Collection. There is one ICR for each
Collection.
The Coast Guard invites comments on
whether this ICR should be granted
based on the Collection being necessary
for the proper performance of
Departmental functions. In particular,
the Coast Guard would appreciate
comments addressing: (1) The practical
utility of the Collection; (2) the accuracy
of the estimated burden of the
Collection; (3) ways to enhance the
quality, utility, and clarity of
information subject to the Collection;
and (4) ways to minimize the burden of
the Collection on respondents,
including the use of automated
collection techniques or other forms of
information technology. In response to
your comments, we may revise this ICR
or decide not to seek an extension of
approval for the Collection. We will
consider all comments and material
received during the comment period.
We encourage you to respond to this
request by submitting comments and
related materials. Comments must
contain the OMB Control Number of the
ICR and the docket number of this
request, [USCG–2018–0879], and must
be received by December 31, 2018.
[FR Doc. 2018–23613 Filed 10–29–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2018–0879]
Information Collection Request to
Office of Management and Budget;
OMB Control Number: 1625–0088
Coast Guard, DHS.
Sixty-day notice requesting
comments.
AGENCY:
ACTION:
In compliance with the
Paperwork Reduction Act of 1995, the
U.S. Coast Guard intends to submit an
Information Collection Request (ICR) to
the Office of Management and Budget
(OMB), Office of Information and
Regulatory Affairs (OIRA), requesting an
extension of its approval for the
following collection of information:
1625–0088, Voyage Planning for Tank
Barge Transits in the Northeast United
States. Our ICR describes the
information we seek to collect from the
public. Before submitting this ICR to
OIRA, the Coast Guard is inviting
comments as described below.
DATES: Comments must reach the Coast
Guard on or before December 31, 2018.
ADDRESSES: You may submit comments
identified by Coast Guard docket
number [USCG–2018–0879] to the Coast
Guard using the Federal eRulemaking
Portal at https://www.regulations.gov.
See the ‘‘Public participation and
request for comments’’ portion of the
SUPPLEMENTARY INFORMATION section for
further instructions on submitting
comments.
A copy of the ICR is available through
the docket on the internet at https://
www.regulations.gov. Additionally,
copies are available from: Commandant
(CG–612), ATTN: Paperwork Reduction
Act Manager, U.S. Coast Guard, 2703
Martin Luther King Jr Ave. SE, STOP
7710, Washington, DC 20593–7710.
FOR FURTHER INFORMATION CONTACT: Mr.
Anthony Smith, Office of Information
Management, telephone 202–475–3532,
or fax 202–372–8405, for questions on
these documents.
SUPPLEMENTARY INFORMATION:
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Submitting Comments
We encourage you to submit
comments through the Federal
eRulemaking Portal at https://
www.regulations.gov. If your material
cannot be submitted using https://
www.regulations.gov, contact the person
in the FOR FURTHER INFORMATION
CONTACT section of this document for
alternate instructions. Documents
mentioned in this notice, and all public
comments, are in our online docket at
https://www.regulations.gov and can be
viewed by following that website’s
instructions. Additionally, if you go to
the online docket and sign up for email
alerts, you will be notified when
comments are posted.
We accept anonymous comments. All
comments received will be posted
without change to https://
www.regulations.gov and will include
E:\FR\FM\30OCN1.SGM
30OCN1
]]>Agencies
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Pages 54605-54606]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23613]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Ancillary
Studies Application Review.
Date: November 2, 2018.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 54606]]
Place: National Institute of Arthritis, Musculoskeletal and Skin
Diseases, 6701 Democracy Boulevard, Room 814, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Helen Lin, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
800, Bethesda, MD 20892, 301-594-4952, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; NIAMS Skin
P30 Review Meeting.
Date: November 5-6, 2018.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
814, Bethesda, MD 20892, 301-451-4838, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; Training
Grants Review.
Date: November 14, 2018.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: 6701 Democracy Boulevard, Suite 820, Scientific Review
Branch, National Institute of Arthritis, Musculoskeletal and Skin
Diseases, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases 6701 Democracy Boulevard, Suite
820, Bethesda, MD 20892, 301-827-7835, [email protected].
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; MSK P30
Review Meeting.
Date: November 15-16, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda,
Bethesda, MD 20852.
Contact Person: Yin Liu, MD, Ph.D., Scientific Review Branch,
National Institute of Health, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Suite
824, Bethesda, MD 20892, 301-594-8919, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: October 24, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-23613 Filed 10-29-18; 8:45 am]
BILLING CODE 4140-01-P
